These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7949466)
1. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Aftab DT; Yang JM; Hait WN Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466 [TBL] [Abstract][Full Text] [Related]
2. Involvement of phospholipase C in heat-shock-induced phosphorylation of P-glycoprotein in multidrug resistant human breast cancer cells. Yang JM; Chin KV; Hait WN Biochem Biophys Res Commun; 1995 May; 210(1):21-30. PubMed ID: 7741743 [TBL] [Abstract][Full Text] [Related]
3. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin. Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242 [TBL] [Abstract][Full Text] [Related]
4. Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Ahmad S; Glazer RI Mol Pharmacol; 1993 Jun; 43(6):858-62. PubMed ID: 8100351 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Schwartz GK; Arkin H; Holland JF; Ohnuma T Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824 [TBL] [Abstract][Full Text] [Related]
6. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Yang JM; Chin KV; Hait WN Cancer Res; 1996 Aug; 56(15):3490-4. PubMed ID: 8758935 [TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi. Fairchild CR; Moscow JA; O'Brien EE; Cowan KH Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772 [TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959 [TBL] [Abstract][Full Text] [Related]
10. Effect of protein kinase C on multidrug resistance of multidrug-resistant colorectal cancer LoVo/Adr cells. Ma Q; Zhang ZS; Zhang YL; Wang QY; Lai ZS Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):626-8. PubMed ID: 12376294 [TBL] [Abstract][Full Text] [Related]
11. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358 [TBL] [Abstract][Full Text] [Related]
12. Stable expression of a cDNA encoding rat brain protein kinase C-beta I confers a multidrug-resistant phenotype on rat fibroblasts. Fan D; Fidler IJ; Ward NE; Seid C; Earnest LE; Housey GM; O'Brian CA Anticancer Res; 1992; 12(3):661-7. PubMed ID: 1622123 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162 [TBL] [Abstract][Full Text] [Related]
16. Correlation of multidrug resistance with up-regulation of protein kinase C expression in KBV200 cells. Yuan YW; Sun AM; Li CG Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1341-3, 1356. PubMed ID: 16305951 [TBL] [Abstract][Full Text] [Related]
17. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx. Drew L; Groome N; Warr JR; Rumsby MG Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200 [TBL] [Abstract][Full Text] [Related]
18. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
19. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675 [TBL] [Abstract][Full Text] [Related]
20. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Chambers TC; Zheng B; Kuo JF Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]